Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00012558 · ClinicalTrials.gov registry record · NA
Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)
A NA study, sponsored by National Institute of Mental Health (NIMH).
- Completed
- Registry status
- NA
- Development phase
- 5,000
- Enrollment target
NCT00012558 is a NA study that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 5,000 participants.
The verdict
NCT00012558, a NA study, has completed, sponsored by National Institute of Mental Health (NIMH).
- COMPLETED
- Registry status
- NA
- Development phase
- 5,000 participants
- Enrollment target
Study Summary
A long-term study of current treatments for bipolar disorder, including medications and psychosocial therapies.
Interventions
- DRUG paroxetine
- DRUG bupropion
- DRUG lamotrigine
- DRUG lithium
- DRUG valproate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 1998-09 |
| Est. Completion | 2005-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00012558
The ClinicalTrials.gov registry entry for NCT00012558 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which paroxetine is the first listed.
NCT00012558 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00012558 about?
NCT00012558 is a clinical study titled "Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)". A long-term study of current treatments for bipolar disorder, including medications and psychosocial therapies.
What is the current status of trial NCT00012558?
This trial is currently completed. It is a NA study. The enrollment target is 5,000 participants. The study started on 1998-09. Estimated completion is 2005-09.
What interventions are being tested in trial NCT00012558?
The interventions under investigation include: paroxetine (DRUG), bupropion (DRUG), lamotrigine (DRUG), lithium (DRUG), valproate (DRUG).
Who is sponsoring clinical trial NCT00012558?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.